Non-life legacy deals up 28% for Q1 after Aspen deal: PwC
  • X
  • LinkedIn
  • Email
  • Show more sharing options
  • Copy Link URLCopied!
  • Print
  • X
  • LinkedIn
  • Email
© 2024 Insider International Limited, company number 15236286, 4 Bouverie Street, London, EC4Y 8AX. Part of the Delinian Group. All rights reserved.

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement
Cookies Settings

Non-life legacy deals up 28% for Q1 after Aspen deal: PwC

Luke Harrison
16 May 2022
  • X
  • LinkedIn
  • Email
  • Show more sharing options
  • Copy Link URLCopied!
  • Print
  • X
  • LinkedIn
  • Email
business background of businessman having handshake

The total value of executed deals in the non-life legacy market for Q1 2022 rose 28% to $4.2bn, compared to $3.3bn during the same period last year, according to a PwC report.

The report on run-off transactions shows that despite a marginal drop in dealflow to 11 from 12 deals in the first quarter of 2021, the market’s appetite to execute on high-value legacy portfolios appears to remain robust.

As

Enter your e-mail to claim a free trial:

Uncover exclusive insights tailored for insurance leaders

    • Stay Informed: Access exclusive industry insights
    • Gain a competitive advantage: Hear first about tactical developments
    • Make better decisions: Understand market dynamics in crucial lines of business
Take a free trial Already a subscriber? Login now

Topics

NewsLondon marketLegacyAspen
Luke_Harrison.png
Luke Harrison
Reporter
Gift this article